Diagnosis of early atherosclerotic lesions, and selected atherosclerotic risk factors, in patients with systemic lupus erythematosus

被引:8
作者
Fischer, Katarzyna [1 ]
Brzosko, Marek [1 ]
机构
[1] Pomeranian Med Univ, Dept Rheumatol & Internal Dis, Szczecin, Poland
来源
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE | 2009年 / 119卷 / 11期
关键词
antiphospholipid syndrome; atherosclerosis; imaging study; risk factors; systemic lupus erythematosus; PRIMARY ANTIPHOSPHOLIPID SYNDROME; INTIMA-MEDIA THICKNESS; PERIPHERAL VASCULAR-DISEASE; CORONARY-ARTERY-DISEASE; ANKLE-BRACHIAL INDEX; LOW-DENSITY-LIPOPROTEIN; HUMAN ENDOTHELIAL-CELLS; PULSE-WAVE VELOCITY; PREMATURE ATHEROSCLEROSIS; CAROTID PLAQUE;
D O I
10.20452/pamw.827
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Early diagnosis of subclinical atherosclerosis can be established using noninvasive imaging techniques, which enable to assess atherosclerotic lesions at different stages of their development, from endothelial dysfunction, through morphological lesions in the arteries, to advanced atherosclerotic plaques. Given high risk of accelerated development of atherosclerotic lesions in patients with systemic lupus erythematosus (SLE), these techniques should be incorporated in routine diagnostic evaluation in this population. Cardiovascular risk factors in patients with SLE differ significantly from those observed in the general population. Chronic inflammation and the presence of autoantibodies play the key role, while classic risk factors are less important. Subclinical atherosclerotic lesions can be detected in 30% to 40% of the SLE patients. The occurrence of severe symptoms in the cardiovascular and central nervous systems can be caused by such lesions. Recent data indicate that the main causes of death in this patient group represent cardiovascular complications. Early identification of patients in the risk group allows to implement appropriate prophylactic and therapeutic procedures.
引用
收藏
页码:736 / 742
页数:7
相关论文
共 50 条
  • [21] The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
    Blachut, Dominika
    Przywara-Chowaniec, Brygida
    Harpula, Jan
    Tomasik, Andrzej
    Nowalany-Kozielska, Ewa
    Morawiec, Beata
    ARCHIVES OF RHEUMATOLOGY, 2022, 37 (04) : 495 - 503
  • [22] The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus
    Blachut, Dominika
    Przywara-Chowaniec, Brygida
    Harpula, Jan
    Tomasik, Andrzej
    Nowalany-Kozielska, Ewa
    Morawiec, Beata
    ARCHIVES OF RHEUMATOLOGY, 2022, : I - IX
  • [23] Risk factors for osteonecrosis in systemic lupus erythematosus
    Mont, MA
    Glueck, CJ
    Pacheco, IH
    Wang, P
    Hungerford, DS
    Petri, M
    JOURNAL OF RHEUMATOLOGY, 1997, 24 (04) : 654 - 662
  • [24] Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms
    Rhew, EY
    Ramsey-Goldman, R
    AUTOIMMUNITY REVIEWS, 2006, 5 (02) : 101 - 105
  • [25] Risk factors for hypercreatinemia in patients with systemic lupus erythematosus
    Rzany, B
    Coresh, J
    Whelton, PK
    Petri, M
    LUPUS, 1999, 8 (07) : 532 - 540
  • [26] Atherosclerosis risk factors in systemic lupus erythematosus
    Manzi S.
    Agarwal S.
    Elliott J.R.
    Current Rheumatology Reports, 2009, 11 (4) : 241 - 247
  • [27] Risk Factors for Development of Coronary Artery Disease in Women with Systemic Lupus Erythematosus
    Goldberg, Robert J.
    Urowitz, Murray B.
    Ibanez, Dominique
    Nikpour, Mandana
    Gladman, Dafna D.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (11) : 2454 - 2461
  • [28] Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease?
    Kitumnuaypong, T
    Scalzi, LV
    Nalbant, S
    Von Feldt, JM
    Schumacher, HR
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (03) : 339 - 342
  • [29] Absence of Chlamydia pneumoniae and Signs of Atherosclerotic Cardiovascular Disease in Adolescents with Systemic Lupus Erythematosus
    Corinna S. Bowser
    Swati Kumar
    Louis Salciccioli
    Andrei Kutlin
    Jason Lazar
    Imran Rahim
    Amy Suss
    Stephan Kohlhoff
    Margaret R. Hammerschlag
    Hamid Jack Moallem
    Pediatric Cardiology, 2008, 29 : 545 - 551
  • [30] Soluble receptors of TNF-alpha: Association with atherosclerotic vascular affection in systemic lupus erythematosus in males
    Ilyina, A. E.
    Klyukvina, N. G.
    Aleksandrova, E. N.
    Popkova, T. V.
    Novikov, A. A.
    Novikova, D. S.
    Mach, E. S.
    Nasonov, E. L.
    TERAPEVTICHESKII ARKHIV, 2006, 78 (06) : 20 - 24